Vous avez cherché: procoagulant (Anglais - Maltais)

idarucizumab alone has shown no procoagulant effect measured as etp.
idarucizumab waħdu ma wera ebda effett prokoagulanti mkejjel bħala etp.

these changes in turn lead to a procoagulant state, resulting in microvascular thrombosis.
dan it-tibdil, sussegwentement iwassal għal stat prokoagulanti, li jirriżulta fi trombożi mikrovaskulari.

subsequently, in the initial phase of treatment, the activity of protein c is more rapidly suppressed than that of the procoagulant factors.
għalhekk, fil-fażi inizjali tal-kura, l-attività tal-proteina Ċ tiġi mrażżna aktar malajr minn dik tal-fatturi proagulanti.

these inhibitors are invariably igg immunoglobulins directed against the factor viii procoagulant activity, which are quantified in modified bethesda units (bu) per ml of plasma.
dawn is- sustanzi inibituri huma immunoglobulini tat- tip igg, li jaġixxu kontra l- attività pro- koagulanti tal- fattur viii mkejla b 'unitajiet bethesda mmodifikati (bu) għal kull ml ta ’ plażma.

these inhibitors are usually iggs directed against the factor viii procoagulant activity, which are quantified in bethesda units (bu) per ml of plasma using the modified bethesda assay.
dawn l- impedituri huma normalment immunoglobulini igg diretti lejn l- attività prokoagulanti tal- fattur viii, li jiġu kwantifikabbli f’ unitajiet bethesda (bu) għal kull ml ta ’ plażma billi tintuża l- analiżi modifikata ta ’ bethesda.

these inhibitors are usually igg immunoglobulins directed against the factor viii procoagulant activity, which are quantified in bethesda units (bus) per ml of plasma using the nijmegen modification of the bethesda assay.
dawn l- inibituri x’ aktarx huma immunoglobulini igg immirati kontra l- attività prokoagulanti tal- fattur viii, li huma kkwantifikati f’ unitajiet bethesda (bu) għal kull ml ta ’ plażma meta tintuża l- modifikazzjoni ta ’ nijmegen tal- assaġġ ta ’ bethesda.

also, in vitro, defibrotide has been shown to increase tissue-type plasminogen activator (t-pa) function and decrease plasminogen activator inhibitor-1 (pai-1) activity resulting in a decrease in procoagulant activity and an increase in the fibrinolytic potential of endothelial cells.
barra minn hekk, defibrotide intwera li jżid il-funzjoni tal-attivatur tal-plasminoġen tat-tip tat-tessut (t- pa) u jnaqqas l-attività tal-inibitur-1 tal-attivatur tal-plasminogen (pai-1) u dan jirriżulta fi tnaqqis fl- attività prokoagulanti u f'żieda fil-potenzjal fibrinolitika taċ-ċelloli endoteljali.